JETi Peripheral Thrombectomy Registry (JETi)

The JETi Registry is a prospective, multi-center, observational study to collect real-world data on the safety, performance, and clinical benefits of the JETi® Peripheral Thrombectomy System (JETi System) for the treatment of acute/subacute thrombosis in the peripheral vasculature.

Stanford is currently accepting patients for this trial.

Stanford Investigator(s):

William Kuo, MD

Intervention(s):

device: JETi Peripheral Thrombectomy System

 

Eligibility

Inclusion Criteria:

  • Subject is expected to be treated for acute/subacute thrombosis in the peripheral vasculature with the JETi Peripheral Thrombectomy System.
  • Subject or legally authorized representative must provide written informed consent
  • Subject must be ≥ 18 years of age

 

Exclusion Criteria:

  • Subject has previously been registered in the JETi Registry in the last 12 months unless treated in the contralateral limb/different anatomy; patients treated in the contralateral limb/different anatomy within the last 12 months may re-enroll in the study.
  • Subject is currently participating in another drug or device clinical investigation.
  • Subject has active symptoms and/or a positive test result of COVID-19 or other rapidly spreading novel infectious agent within the past 20 days.

 

Ages Eligible for Study

18 Years and older

Genders Eligible for Study

All

Not Recruiting

Contact Information

Andrea Otte, DPT

Stanford University School of Medicine
300 Pasteur Drive
Stanford, CA 94305

650-736-4183